Best Warren Buffett Stocks To Buy For 2019

&l;p&g;&l;img class=&q;dam-image getty size-large wp-image-911908838&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/911908838/960×0.jpg?fit=scale&q; data-height=&q;689&q; data-width=&q;960&q;&g; (Photo credit:&a;nbsp;Jason Redmond/AFP/Getty Images)

It&s;s good to be Jeff Bezos: The Amazon founder saw his fortune rise by another $3.2 billion on Friday. &l;!–donotpaginate–&g;

He is now worth&a;nbsp;&l;span&g;$118.8 billion, solidifying&a;nbsp;his title as the richest person on the planet, according to &l;em&g;Forbes&l;/em&g; real-time billionaire rankings. He briefly topped $120 billion, crossing a new threshold, during the day. In recent months, he has surpassed both&a;nbsp;Bill Gates (today worth $92.1 billion) and Warren Buffett ($89.9 billion).&l;/span&g;

Bezos&s; fortune rose on the back of blockbuster quarterly results&a;nbsp;from Amazon. The e-commerce giant said on Thursday it hauled in a record $1.9 billion in profits in its fourth quarter. R&l;span&g;evenue climbed 38% to $60.5 billion, topping expectations on Wall Street. Investors cheered the results&a;nbsp;and sent the&l;/span&g;&a;nbsp;stock&a;nbsp;up&a;nbsp;3&l;span&g;% on Friday. Shares are up 75% over the last twelve months.&l;/span&g;

Best Warren Buffett Stocks To Buy For 2019: Equity Commonwealth(EQC)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    Equity Commonwealth (NYSE:EQC) continued to steadily sell off its portfolio of real estate holdings, closing three more sales during the quarter, bringing its property count down to 13. As a result, cash flow kept declining. That trend doesn’t show any signs of ending given that the company has more properties on the market and doesn’t yet see a good opportunity to make acquisitions.

  • [By Stephan Byrd]

    HRPT Properties Trust (NYSE:EQC) had its price target boosted by investment analysts at JMP Securities to $33.00 in a report issued on Tuesday. The brokerage currently has a “market outperform” rating on the real estate investment trust’s stock. JMP Securities’ target price points to a potential upside of 4.04% from the company’s previous close.

Best Warren Buffett Stocks To Buy For 2019: Uranium Resources, Inc.(URRE)

Advisors’ Opinion:

  • [By Lisa Levin]

    Uranium Resources, Inc. (NASDAQ: URRE) was down, falling around 12 percent to $2.37 after the company reported a closing of $9.7 million public offering.

  • [By Lisa Levin]

    Uranium Resources, Inc. (NASDAQ: URRE) shares dropped 19 percent to $2.55 after the company reported the pricing of $9.7 million public offering.

Best Warren Buffett Stocks To Buy For 2019: Caleres, Inc.(CAL)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Caleres (CAL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin] Related CRMD Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher 12 Biggest Mid-Day Gainers For Tuesday CorMedix's (CRMD) CEO Khoso Baluch on Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    Related BIOA Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher Mid-Morning Market Update: Markets Edge Higher; Tiffany Earnings Top Estimates BioAmber (BIOA) Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    CorMedix Inc. (NYSE: CRMD) shares fell 27.5 percent to $1.50 after the company reported Q4 results and issued a business update.
    Bioamber Inc (NYSE: BIOA) shares tumbled 23.6 percent to $2.40. BioAmber reported FY16 adjusted loss of $1.07 per share on revenue of $8.3 million.
    The Medicines Company (NASDAQ: MDCO) shares dipped 20.9 percent to $41.62.
    Innocoll Holdings PLC (NASDAQ: INNL) shares fell 20.3 percent to $1.49. Innocoll posted a narrower-than-expected quarter loss, but revenue missed estimates. Stifel Nicolaus downgraded Innocoll from Buy to Hold.
    Rosetta Genomics Ltd. (USA) (NASDAQ: ROSG) shares declined 20.3 percent to $3.83. On Thursday, Rosetta Genomics disclosed a 1-for-12 reverse stock split.
    Esperion Therapeutics Inc (NASDAQ: ESPR) shares dropped 19.9 percent to $23.76. Esperion Therapeutics shares have jumped 106.19 percent over the past 52 weeks, while the S&P 500 index has gained 16.70 percent in the same period.
    AmTrust Financial Services Inc (NASDAQ: AFSI) tumbled 18.3 percent to $17.65. AmTrust Financial disclosed that it will delay its annual report filing for the fiscal year ended December 31, 2016.
    Qualstar Corporation (NASDAQ: QBAK) slipped 17.7 percent to $6.85. Qualstar reported a Q4 loss of $0.20 per share on revenue of $2.2 milli
  • [By Lisa Levin]

    Shares of Caleres Inc (NYSE: CAL) got a boost, shooting up 12 percent to $31.99 after the company posted upbeat Q3 earnings.

    QAD Inc. (NASDAQ: QADA) shares were also up, gaining 14 percent to $29.44 after the company posted strong Q3 results.

Best Warren Buffett Stocks To Buy For 2019: AMERISAFE, Inc.(AMSF)

Advisors’ Opinion:

  • [By Ethan Ryder]

    BidaskClub lowered shares of AMERISAFE (NASDAQ:AMSF) from a hold rating to a sell rating in a report released on Friday.

    Other research analysts have also issued reports about the stock. TheStreet raised shares of AMERISAFE from a c+ rating to a b rating in a report on Thursday, April 26th. ValuEngine raised shares of AMERISAFE from a hold rating to a buy rating in a report on Thursday, March 1st. Boenning Scattergood reaffirmed a hold rating on shares of AMERISAFE in a report on Tuesday, February 27th. Keefe, Bruyette & Woods initiated coverage on shares of AMERISAFE in a report on Thursday, April 5th. They issued a market perform rating and a $54.00 price target for the company. Finally, Zacks Investment Research lowered shares of AMERISAFE from a hold rating to a strong sell rating in a report on Tuesday, March 6th. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating and four have assigned a buy rating to the company’s stock. AMERISAFE currently has a consensus rating of Hold and a consensus target price of $63.00.

  • [By Max Byerly]

    ILLEGAL ACTIVITY NOTICE: “$0.73 Earnings Per Share Expected for Amerisafe, Inc. (AMSF) This Quarter” was first posted by Ticker Report and is the property of of Ticker Report. If you are viewing this story on another site, it was illegally stolen and reposted in violation of international copyright and trademark legislation. The original version of this story can be viewed at www.tickerreport.com/banking-finance/3362844/0-73-earnings-per-share-expected-for-amerisafe-inc-amsf-this-quarter.html.

Leave a Reply

Your email address will not be published. Required fields are marked *